Immunome, Inc. (IMNM)
18.70
-0.37
(-1.94%)
USD |
NASDAQ |
Nov 12, 16:00
18.71
+0.01
(+0.05%)
After-Hours: 20:00
Immunome Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2025 | -1.08K% |
| March 31, 2025 | -1.42K% |
| December 31, 2024 | -2.93K% |
| September 30, 2024 | -1.62K% |
| June 30, 2024 | -1.53K% |
| Date | Value |
|---|---|
| March 31, 2024 | -12.58K% |
| December 31, 2023 | -2.42K% |
| September 30, 2023 | -121.9% |
| June 30, 2023 | -130.4% |
| March 31, 2023 | -180.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Revolution Medicines, Inc. | -206.2% |
| Erasca, Inc. | -- |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.30% |
| Return on Assets | -52.87% |
| Return on Invested Capital | -56.67% |
| Return on Net Operating Assets | -1.50K% |